IFM-2427

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameIFM-2427
Drug Alias NameIFM-2427DFV-890
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Cryopyrin-Associated Periodic SyndromesBone Marrow Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[22] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIfm Tre
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsCryopyrin-Associated Periodic SyndromesBone Marrow DiseasesCoronary Disease +[4] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A